581 Matching-adjusted indirect treatment comparison of tremelimumab + durvalumab + chemotherapy vs pembrolizumab + chemotherapy and nivolumab + ipilimumab + chemotherapy for first-line metastatic NSCLC
Regular and Young Investigator Award Abstracts（2022）
关键词
chemotherapy,pembrolizumab,indirect treatment comparison,durvalumab,matching-adjusted,first-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要